MannKind Corp (MNKD)
7.02
+0.06
(+0.86%)
USD |
NASDAQ |
Nov 14, 16:00
7.26
+0.24
(+3.42%)
Pre-Market: 08:44
MannKind Free Cash Flow: 28.87M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 28.87M |
| June 30, 2024 | 18.24M |
| March 31, 2024 | 3.103M |
| December 31, 2023 | -8.347M |
| September 30, 2023 | -31.62M |
| June 30, 2023 | -57.24M |
| March 31, 2023 | -72.12M |
| December 31, 2022 | -88.27M |
| September 30, 2022 | -98.33M |
| June 30, 2022 | -89.42M |
| March 31, 2022 | -82.77M |
| December 31, 2021 | -73.18M |
| September 30, 2021 | -59.88M |
| June 30, 2021 | -53.92M |
| March 31, 2021 | -35.25M |
| December 31, 2020 | -32.91M |
| September 30, 2020 | -33.88M |
| June 30, 2020 | -73.43M |
| March 31, 2020 | -90.55M |
| December 31, 2019 | -91.05M |
| September 30, 2019 | -60.84M |
| June 30, 2019 | -21.75M |
| March 31, 2019 | -27.95M |
| December 31, 2018 | -37.73M |
| September 30, 2018 | -92.70M |
| Date | Value |
|---|---|
| June 30, 2018 | -102.05M |
| March 31, 2018 | -94.94M |
| December 31, 2017 | -64.78M |
| September 30, 2017 | -47.55M |
| June 30, 2017 | -47.35M |
| March 31, 2017 | -38.82M |
| December 31, 2016 | -79.23M |
| September 30, 2016 | -89.35M |
| June 30, 2016 | -87.40M |
| March 31, 2016 | -98.24M |
| December 31, 2015 | -67.52M |
| September 30, 2015 | -85.36M |
| June 30, 2015 | 26.54M |
| March 31, 2015 | 17.20M |
| December 31, 2014 | -20.01M |
| September 30, 2014 | -19.52M |
| June 30, 2014 | -143.43M |
| March 31, 2014 | -141.63M |
| December 31, 2013 | -136.72M |
| September 30, 2013 | -124.66M |
| June 30, 2013 | -125.91M |
| March 31, 2013 | -121.17M |
| December 31, 2012 | -120.50M |
| September 30, 2012 | -112.84M |
| June 30, 2012 | -115.09M |
Free Cash Flow Range, Past 5 Years
-98.33M
Minimum
Sep 2022
28.87M
Maximum
Sep 2024
-51.10M
Average
-58.56M
Median
Free Cash Flow Benchmarks
| Mirum Pharmaceuticals Inc | -39.22M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.331M |
| Cash from Investing (Quarterly) | -41.26M |
| Cash from Financing (Quarterly) | -2.342M |
| Free Cash Flow Per Share (Quarterly) | 0.0278 |
| Free Cash Flow to Equity (Quarterly) | 7.55M |
| Free Cash Flow to Firm (Quarterly) | 12.56M |
| Free Cash Flow Yield | 1.43% |